Artículos por temáticas

Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer's Disease

Chen J, Zhu Z, Xu F, Dou B, Sheng Z, Xu Y.

Cells. 2025 Jan 22;14(3):164. doi: 10.3390/cells14030164.

The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias

Huang C, Wei Z, Zheng N, Yan J, Zhang J, Ye X, Zhao W.

Alzheimers Dement. 2025 Feb;21(2):e14618. doi: 10.1002/alz.14618.

The Bidirectional Relationship Between Epilepsy and Alzheimer's Disease

Stewart D, Johnson EL.

Curr Neurol Neurosci Rep. 2025 Feb 8;25(1):18. doi: 10.1007/s11910-025-01404-y.

The Missing Link in Antiamyloid Therapy

Mandal PK, Maroon JC, Guha Roy R, Patira R, Gogniat MA, Sindhu B.

ACS Chem Neurosci. 2025 Feb 5;16(3):276-280. doi: 10.1021/acschemneuro.4c00825. Epub 2025 Jan 14.

A multifactorial lens on risk factors promoting the progression of Alzheimer's disease

Parker J, Moris JM, Goodman LC, Paidisetty VK, Vanegas V, Turner HA, Melgar D, Koh Y.

Brain Res. 2025 Jan 1;1846:149262. doi: 10.1016/j.brainres.2024.149262. Epub 2024 Oct 5.

Antibiotic Use and Subsequent Cognitive Decline and Dementia Risk in Healthy Older Adults

Wang Y, Zhou Z, Broder JC, Woods RL, Orchard SG, Wolfe R, Ernst EJ, Ryan J, Ernst ME, Chan AT.

Neurology. 2025 Jan 14;104(1):e210129. doi: 10.1212/WNL.0000000000210129. Epub 2024 Dec 18.

Bidirectional association between breast cancer and dementia: a systematic review and meta-analysis of observational studies

Bao F, Yu L, Zhang X, Mu Q.

PeerJ. 2025 Jan 31;13:e18888. doi: 10.7717/peerj.18888. eCollection 2025.

Coffee and tea consumption and dementia risk: The role of sex and vascular comorbidities

Hou KC, Chen YC, Chen TF, Sun Y, Wen LL, Yip PK, Chu YM, Chiou JM, Chen JH.

J Formos Med Assoc. 2025 Feb;124(2):178-185. doi: 10.1016/j.jfma.2024.04.018. Epub 2024 May 6.

Meta-analysis reveals an inverse relationship between Alzheimer's disease and cancer

Zheng G, Xu M, Dong Z, Abdelrahman Z, Wang X.

Behav Brain Res. 2025 Feb 26;478:115327. doi: 10.1016/j.bbr.2024.115327. Epub 2024 Nov 8.

Perspective: Emerging challenges for a future ADNI

Khachaturian Z, Carrillo MC, Khachaturian AS.

Alzheimers Dement. 2025 Feb;21(2):e14534. doi: 10.1002/alz.14534.

Spontaneous haemorrhage in subdural hygroma in an Alzheimer's patient on lecanemab

Watanabe M, Okochi R, Tezuka T, Ito D.

BMJ Case Rep. 2025 Jan 8;18(1):e263497. doi: 10.1136/bcr-2024-263497.

Metabolic Syndrome and the Risk of Alzheimer's Disease: A Meta-Analysis

Feng Y, Cheng L, Zhou W, Lu J, Huang H.

Metab Syndr Relat Disord. 2025 Feb;23(1):30-40. doi: 10.1089/met.2024.0155. Epub 2024 Nov 19.

APOE4, Alzheimer's and periodontal disease: A scoping review

Arévalo-Caro C, Arce Retana M, Losada Amaya S, Arboleda H, Gallart-Palau X, Serra A.

Ageing Res Rev. 2025 Mar;105:102649. doi: 10.1016/j.arr.2024.102649. Epub 2025 Jan 24.

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial

Ayton S, Barton D, Brew B, Brodtmann A, Clarnette R, Desmond P, Devos D, Ellis KA, Fazlollahi A, Fradette C, Goh AMY, Kalinowski P, Kyndt C, Lai R, Lim YY, Maruff P, O'Brien TJ, Rowe C, Salvado O, Sch

JAMA Neurol. 2025 Jan 1;82(1):11-18. doi: 10.1001/jamaneurol.2024.3733.

Communication Bridge-2 randomized controlled trial: Recruitment and baseline features

Rogalski E, Bona M, Esparza M, Mooney A, Fried-Oken M, Rademaker A, Roberts A.

Alzheimers Dement. 2025 Jan;21(1):e14168. doi: 10.1002/alz.14168. Epub 2024 Nov 26.